ESES treated with clobazam
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
20
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Electrical Status Epilepticus in Sleep
Conditions
Electrical Status Epilepticus in Sleep
Trial Timeline
Jul 1, 2012 → Jul 1, 2015
NCT ID
NCT02127918About ESES treated with clobazam
ESES treated with clobazam is a pre-clinical stage product being developed by Lundbeck for Electrical Status Epilepticus in Sleep. The current trial status is completed. This product is registered under clinical trial identifier NCT02127918. Target conditions include Electrical Status Epilepticus in Sleep.
Hype Score Breakdown
Clinical
5
Activity
2
Company
7
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02127918 | Pre-clinical | Completed |
Competing Products
1 competing product in Electrical Status Epilepticus in Sleep
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Epidiolex 100 mg/mL Oral Solution | Jazz Pharmaceuticals | Phase 1 | 30 |